Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Inmune Bio (INMB) Receivables Refunds (2017 - 2023)

Inmune Bio (INMB) has disclosed Receivables Refunds for 7 consecutive years, with $176000.0 as the latest value for Q3 2023.

  • Quarterly Receivables Refunds rose 54.39% to $176000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $176000.0 through Sep 2023, up 54.39% year-over-year, with the annual reading at $362000.0 for FY2022, 38.75% down from the prior year.
  • Receivables Refunds hit $176000.0 in Q3 2023 for Inmune Bio, up from $112000.0 in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $591000.0 in Q4 2021 to a low of $51000.0 in Q2 2021.
  • Historically, Receivables Refunds has averaged $201997.6 across 5 years, with a median of $148828.5 in 2020.
  • Biggest YoY gain for Receivables Refunds was 423.01% in 2021; the steepest drop was 67.1% in 2021.
  • Year by year, Receivables Refunds stood at $105842.0 in 2019, then rose by 6.76% to $113000.0 in 2020, then soared by 423.01% to $591000.0 in 2021, then plummeted by 38.75% to $362000.0 in 2022, then tumbled by 51.38% to $176000.0 in 2023.
  • Business Quant data shows Receivables Refunds for INMB at $176000.0 in Q3 2023, $112000.0 in Q2 2023, and $396000.0 in Q1 2023.